Evidence map›Paper›PMID 21710276›Full record

Trial reportJournal of clinical immunology2011

Acute exposure to 50-Hz magnetic fields increases interleukin-6 in young healthy men.

Brahim Selmaoui, Jacques Lambrozo, Linda Sackett-Lundeen, Erhard Haus, Yvan Touitou

Open access · greenAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Brahim SelmaouiDepartment of Experimental Toxicology, INERIS, Parc ALATA, BP2, 60550, Verneuil-en-Halatte, France. brahim.selmaoui@ineris.fr
Jacques Lambrozo
Linda Sackett-Lundeen
Erhard Haus
Yvan Touitou
University of Minnesota · USÉlectricité de France (France) · FRFondation Ophtalmologique Adolphe de Rothschild · FRInstitut national de l'environnement industriel et des risques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some epidemiologic studies have suggested that extremely low frequency magnetic fields might affect human health and, in particular, that the incidence of certain types of cancer might increase among individuals living or working in environments exposed to such fields. This study is part of a broad study we conducted in humans. The study presented here was designed to look for possible effects of acute exposure to 50-Hz magnetic fields (10 μT) on the interleukin 1 beta (IL-1β), interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin-1 receptor antagonist (IL-1RA), and the interleukin-2 receptor (IL-2R) production. Thirty-two young men (20-30 years old) were divided into two groups (sham-exposed or control group and exposed group) of 16 subjects each. All subjects participated in two 24-h experiments to evaluate the effects of both continuous and intermittent (1 h "off" and 1 h "on" with the field switched "on" and "off" every 15 s) exposure to linearly polarized magnetic fields. The subjects were exposed to the magnetic field from 2300 to 0800 while recumbent. Blood samples were collected during each session at 11:00, 17:00, 22:00, 01:00, 04:00, 06:00, and 08:00. Results showed that exposure to 50-Hz magnetic fields (10 μT) significantly increases IL-6 when subjects were exposed to an intermittent magnetic field. However, no effect has been observed on interleukin IL-1β, IL-2, IL-1RA, and IL-2R.

Indexed as

AdultEnvironmental ExposureGene Expression RegulationHumansInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Leukocytes, MononuclearMagnetic FieldsMaleRadio WavesReceptors, Interleukin-2Young AdultInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Receptors, Interleukin-2

Identifiers

PMID21710276
OpenAlexW2080468328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.